White label ELPA - ClinicalTrials.eu

Study of CART84 Treatment for Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia and T-Cell Acute Lymphoblastic Leukemia

Recruiting

2 1 1
Investigated diseases:
Evaluation of 68Ga-FAPI PET/CT scan effectiveness in monitoring treatment response in patients with peritoneal metastases receiving intraperitoneal chemotherapy

Recruiting

1 1 1
Investigated diseases:
- Metastases to peritoneum
Investigated drugs:
- (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
Study of tarlatamab with durvalumab, carboplatin and etoposide versus standard treatment in patients with previously untreated extensive stage small cell lung cancer

Recruiting

3 1 1 1
Investigated diseases:
- Small cell lung cancer extensive stage
Investigated drugs:
+7
Study of momelotinib tablets in patients with anemia caused by low-risk myelodysplastic syndrome

Recruiting

2 1 1
Investigated diseases:
- Myelodysplastic syndrome
Investigated drugs:
- Momelotinib Dihydrochloride Monohydrate
Study of Mosunetuzumab Treatment in Patients with Systemic Lupus Erythematosus with or without Lupus Nephritis

Recruiting

2 1 1
Investigated diseases:
- Systemic lupus erythematosus
Investigated drugs:
- Mosunetuzumab
Comparing weekly insulin icodec and daily insulin glargine with insulin aspart in adults with type 1 diabetes: a 26-week study of blood sugar control

Recruiting

3 1 1 1
Investigated diseases:
- Type 1 diabetes mellitus
Investigated drugs:
- Insulin Glargine
- Insulin Icodec
Study comparing QL2107 and pembrolizumab in patients with resected non-small cell lung cancer receiving adjuvant therapy

Recruiting

3 1 1 1
Investigated diseases:
- Non-small cell lung cancer
Investigated drugs:
- Pembrolizumab
Evaluation of controlled-ileal-release nicotinic acid tablets compared to placebo for treating people with prediabetes

Recruiting

2 1
Investigated diseases:
- Glucose tolerance impaired
Study of Nucresiran in Adults with Transthyretin Amyloidosis with Cardiomyopathy to Evaluate its Effects on Survival and Heart Problems

Recruiting

3 1
Investigated diseases:
- Cardiomyopathy
+12
Long-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial

Recruiting

3 1 1
Investigated diseases:
- Arteriosclerosis
Investigated drugs:
- Pelacarsen
+14

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies